Page last updated: 2024-10-23

astemizole and Vitiligo

astemizole has been researched along with Vitiligo in 1 studies

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, SM1
Ahn, SK1
Choi, EH1

Other Studies

1 other study available for astemizole and Vitiligo

ArticleYear
Psoriasis occurring in amelanotic lesions.
    The Journal of dermatology, 1998, Volume: 25, Issue:1

    Topics: Administration, Topical; Adult; Albinism; Anti-Inflammatory Agents; Astemizole; Female; Glucocortico

1998